Mutations in CIC and TERT promoter were found in 46% and 43% PM gliomas with 1p19q co-deletion, respectively, while mutations in TP53 and ATRX in 88% and 74% PM gliomas without 1p19q co-deletion, respectively (Additional file 1: Fig. S1). Here, TP53 is linked to central nervous system cancer.